GlassScriptPhysician profile
Richard Lawrence Weil
NPI 1689670556
$473.23
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $124.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $87.56 | 2019-2020 | |
| Tris Pharma INC | $70.36 | 2019-2020 | |
| Welch Allyn | $47.52 | 2020 | |
| Pfizer INC. | $42.25 | 2019 | |
| Trice Medical, INC. | $40.27 | 2019 | |
| Shire North American Group INC | $34.90 | 2019 | |
| Cranial Technologies, INC | $34.56 | 2019 | |
| Ironshore Pharmaceuticals INC. | $23.18 | 2019 | |
| Merck Sharp & Dohme LLC | $22.01 | 2019 | |
| Arbor Pharmaceuticals, INC. | $20.80 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.81 | 2019 | |
| Genentech USA, INC. | $17.29 | 2019 | |
| Glaxosmithkline, LLC. | $13.72 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Weil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.